State PA
Clinical Trials in Pennsylvania
Recruiting clinical trials with at least one study location in Pennsylvania. Data updated daily from ClinicalTrials.gov.
Top Conditions in Pennsylvania
NCT05345951 N/A
Recruiting
Project e-PBI+ - Parent Intervention to Reduce College Student Drinking and Cann...
Condition
Underage Drinking
Enrollment
2,425 pts
Location
United States
Sponsor
Penn State University
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT06990269 Phase 2
Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Condition
Geographic Atrophy Secondary to Age-related Macular Degeneration
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
ADARx Pharmaceuticals, Inc.
NCT06872905 N/A
Recruiting
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endopros...
Condition
Aortoiliac Occlusive Disease
Enrollment
158 pts
Location
United States, Italy, Netherlands
Sponsor
W.L.Gore & Associates
NCT06991556 Phase 2
Recruiting
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone ...
Condition
Metastatic Hormone-sensitive Prostate Cancer
Enrollment
150 pts
Location
United States, Australia, Canada
Sponsor
Novartis Pharmaceuticals
NCT03016819 Phase 3
Recruiting
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarco...
Condition
Alveolar Soft Part Sarcoma
Enrollment
325 pts
Location
United States, China, Italy
Sponsor
Advenchen Laboratories, LLC
NCT06826612 Phase 1, Phase 2
Recruiting
A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's D...
Condition
Huntington Disease
Enrollment
53 pts
Location
United States
Sponsor
Hoffmann-La Roche
NCT07225946 Phase 3
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metas...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
800 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
NCT04704661 Phase 1
Recruiting
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The ...
Condition
Advanced Breast Carcinoma
Enrollment
51 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06972459 Phase 3
Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight a...
Condition
Obesity
Enrollment
600 pts
Location
United States, Argentina, China
Sponsor
Eli Lilly and Company
NCT05388773 Phase 2
Recruiting
Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectabl...
Condition
Oropharynx Cancer
Enrollment
150 pts
Location
United States
Sponsor
Heath Skinner
NCT06732102 N/A
Recruiting
Philly CEAL- DECIDE+ Adaptation
Condition
Disparities
Enrollment
500 pts
Location
United States
Sponsor
University of Pennsylvania
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Pros...
Condition
Prostate Cancer
Enrollment
1,440 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06065657 Phase 2, Phase 3
Recruiting
Effect of Nutritional Ketosis on Alcohol Metabolism
Condition
Ketoses, Metabolic
Enrollment
20 pts
Location
United States
Sponsor
University of Pennsylvania
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
NCT05337241 N/A
Recruiting
Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT
Condition
Refractory Ventricular Tachycardia
Enrollment
130 pts
Location
United States, Canada
Sponsor
Thermedical, Inc.
NCT06941272 Phase 1, Phase 2
Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refr...
Condition
Malignant Neoplasm
Enrollment
50 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT07226895 Phase 1, Phase 2
Recruiting
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT198...
Condition
Clinical High Risk for Psychosis (CHR)
Enrollment
150 pts
Location
United States
Sponsor
Monument Therapeutics Limited
NCT07055854 Phase 1
Recruiting
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Bre...
Condition
Gynecologic Cancers
Enrollment
60 pts
Location
United States
Sponsor
Oregon State University
NCT06829953 N/A
Recruiting
Get ActivE Study for At-risk Youth
Condition
Anhedonia
Enrollment
75 pts
Location
United States
Sponsor
University of Pittsburgh
NCT06568237 Phase 2
Recruiting
A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Mul...
Condition
Multiple System Atrophy
Enrollment
350 pts
Location
United States, France, Germany
Sponsor
Teva Branded Pharmaceutical Pr
NCT06679140 Phase 3
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolesc...
Condition
COVID-19 SARS-CoV-2 Infection
Enrollment
2,330 pts
Location
United States, Argentina, Belgium
Sponsor
Pfizer
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT04462770 Phase 3
Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrom...
Condition
Dravet Syndrome
Enrollment
150 pts
Location
United States, Canada, Georgia
Sponsor
Epygenix